Results 131 to 140 of about 223,141 (305)

Saving and Re-building Lives: an Analysis of the Determinants of Disaster Relief [PDF]

, 2012
We analyse both theoretically and empirically, the factors that influence the amount of humanitarian aid which countries receive when they are struck by natural disasters.
Selvaretnam, Geethanjali, Thampanishvong, Kannika, Ulph, David   +2 more
core  

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

Factors associated with international humanitarian aid appeal for disasters from 1995 to 2015: A retrospective database study. [PDF]

PLoS One, 2023
Cheng L, Hertelendy AJ, Hart A, Law LS, Hata R, Nouaime G, Issa F, Echeverri L, Voskanyan A, Ciottone GR.   +9 more
europepmc   +1 more source

Tumor mutational burden as a determinant of metastatic dissemination patterns

Molecular Oncology, EarlyView.
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal, Andrea Moreno‐Manuel, Miguel Salvadó‐Pertierra, Cristina Santos‐Vivas, Rebeca Sanz‐Pamplona   +4 more
wiley   +1 more source

Understanding leadership challenges faced by humanitarian aid workers: insights from the experiences of NNPHL training participants

Journal of International Humanitarian Action
This paper examines the self-reported leadership challenges experienced by humanitarian aid workers who participated in the National NGO Program on Humanitarian Leadership (NNPHL) Program.
Godfred Nyarko, Ariana Marnicio, Vincenzo Bollettino   +2 more
doaj   +1 more source

An analysis of humanitarian and health aid harmonisation over a decade (2011–2019) of the Syrian conflict

BMJ Global Health
Introduction Aid harmonisation is a key component of donor efforts to make aid more effective by improving coordination and simplifying and sharing information to avoid duplication. This study evaluates the harmonisation of health and humanitarian aid in
Aula Abbara, Kristen Meagher, Preeti Patel, Abdulkarim Ekzayez, Nassim El Achi, Munzer Alkhalil, Maher Alaref, Rim Turkmani, Zedoun Al Zoubi   +8 more
doaj   +1 more source

Psychosocial model of burnout among humanitarian aid workers in Bangladesh: role of workplace stressors and emotion coping. [PDF]

Confl Health, 2023
Foo CYS, Tay AK, Yang Y, Verdeli H.
europepmc   +1 more source

Australia’s response to the Horn of Africa humanitarian crisis, 2011 [PDF]

An evaluation by the Office of Development Effectiveness of Australia’s response to the Horn of Africa humanitarian crisis, 2011. Foreword This report identifies many strengths of the Australian response to the humanitarian crisis in the Horn of ...
Anais Resseguier, Deborah Clifton, Hugo Slim, Joyce Njagi, Karen Ovington, Lewis Sida, Shams Tazi   +6 more
core  

Die Neugestaltung staatlicher humanitärer Hilfe in der Bundesrepublik Deutschland [PDF]

, 1997
Seit Beginn der neunziger Jahre wurden Staaten, internationale Organisationen und Nichtregierungsorganisationen im Rahmen internationaler humanitärer Hilfe zunehmend mit Katastrophen politisch-militärischen Hintergrunds konfrontiert.
Topçu, Yasemin
core  

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source